Division of Hematology
In the Division of Hematology at Children's Hospital of Philadelphia, we provide inpatient and outpatient services for children with hematologic disorders. Our patients are cared for by a multidisciplinary team in a setting designed specifically for children and their families.
FDA Approves Two Gene Therapies for Sickle Cell Disease
![FDA Approves First CRISPR-Based Therapy for Sickle Cell Disease FDA Approves First CRISPR-Based Therapy for Sickle Cell Disease](https://www.chop.edu/sites/default/files/styles/teaser--alt/public/fda-approves-first-crispr-based-therapy-sickle-cell-disease-16x9.png?itok=7aJwwOr9)
The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).